nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA6—saliva—attention deficit hyperactivity disorder	0.0536	0.0827	CbGeAlD
Imatinib—ORM1—saliva—attention deficit hyperactivity disorder	0.0285	0.044	CbGeAlD
Imatinib—NTRK1—midbrain—attention deficit hyperactivity disorder	0.0186	0.0287	CbGeAlD
Imatinib—ABCA3—midbrain—attention deficit hyperactivity disorder	0.0147	0.0227	CbGeAlD
Imatinib—DDR1—midbrain—attention deficit hyperactivity disorder	0.0136	0.0209	CbGeAlD
Imatinib—CA3—forebrain—attention deficit hyperactivity disorder	0.0121	0.0187	CbGeAlD
Imatinib—ABCA3—nervous system—attention deficit hyperactivity disorder	0.0121	0.0186	CbGeAlD
Imatinib—ABCA3—central nervous system—attention deficit hyperactivity disorder	0.0116	0.0179	CbGeAlD
Imatinib—ABCA3—cerebellum—attention deficit hyperactivity disorder	0.0114	0.0175	CbGeAlD
Imatinib—DDR1—cerebellum—attention deficit hyperactivity disorder	0.0105	0.0162	CbGeAlD
Imatinib—CA3—cardiovascular system—attention deficit hyperactivity disorder	0.0102	0.0158	CbGeAlD
Imatinib—HIPK4—brain—attention deficit hyperactivity disorder	0.00935	0.0144	CbGeAlD
Imatinib—PDGFRA—forebrain—attention deficit hyperactivity disorder	0.00929	0.0143	CbGeAlD
Imatinib—ABCA3—brain—attention deficit hyperactivity disorder	0.00924	0.0142	CbGeAlD
Imatinib—CA7—midbrain—attention deficit hyperactivity disorder	0.00872	0.0134	CbGeAlD
Imatinib—CA12—forebrain—attention deficit hyperactivity disorder	0.00858	0.0132	CbGeAlD
Imatinib—DDR1—brain—attention deficit hyperactivity disorder	0.00853	0.0131	CbGeAlD
Imatinib—PIP4K2C—midbrain—attention deficit hyperactivity disorder	0.00838	0.0129	CbGeAlD
Imatinib—CSF1R—forebrain—attention deficit hyperactivity disorder	0.00818	0.0126	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—attention deficit hyperactivity disorder	0.00786	0.0121	CbGeAlD
Imatinib—CA14—midbrain—attention deficit hyperactivity disorder	0.00726	0.0112	CbGeAlD
Imatinib—CSF1R—cardiovascular system—attention deficit hyperactivity disorder	0.00692	0.0107	CbGeAlD
Imatinib—PIP4K2C—nervous system—attention deficit hyperactivity disorder	0.00689	0.0106	CbGeAlD
Imatinib—ABL2—cerebellum—attention deficit hyperactivity disorder	0.00685	0.0106	CbGeAlD
Imatinib—CA1—forebrain—attention deficit hyperactivity disorder	0.0068	0.0105	CbGeAlD
Imatinib—CA7—cerebellum—attention deficit hyperactivity disorder	0.00675	0.0104	CbGeAlD
Imatinib—PIP4K2C—central nervous system—attention deficit hyperactivity disorder	0.00663	0.0102	CbGeAlD
Imatinib—CA3—nervous system—attention deficit hyperactivity disorder	0.00658	0.0101	CbGeAlD
Imatinib—PIP4K2C—cerebellum—attention deficit hyperactivity disorder	0.00648	0.00999	CbGeAlD
Imatinib—CA3—central nervous system—attention deficit hyperactivity disorder	0.00633	0.00976	CbGeAlD
Imatinib—KIT—cardiovascular system—attention deficit hyperactivity disorder	0.00628	0.00968	CbGeAlD
Imatinib—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.00624	0.00961	CbGeAlD
Imatinib—NQO2—midbrain—attention deficit hyperactivity disorder	0.00615	0.00948	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—attention deficit hyperactivity disorder	0.00614	0.00946	CbGeAlD
Imatinib—CA9—cerebellum—attention deficit hyperactivity disorder	0.00592	0.00913	CbGeAlD
Imatinib—CA1—cardiovascular system—attention deficit hyperactivity disorder	0.00575	0.00886	CbGeAlD
Imatinib—CA14—cerebellum—attention deficit hyperactivity disorder	0.00562	0.00866	CbGeAlD
Imatinib—ABL2—brain—attention deficit hyperactivity disorder	0.00556	0.00858	CbGeAlD
Imatinib—CA7—brain—attention deficit hyperactivity disorder	0.00548	0.00845	CbGeAlD
Imatinib—ABL1—cardiovascular system—attention deficit hyperactivity disorder	0.00547	0.00843	CbGeAlD
Imatinib—CSF1R—midbrain—attention deficit hyperactivity disorder	0.0054	0.00833	CbGeAlD
Imatinib—PIP4K2C—brain—attention deficit hyperactivity disorder	0.00526	0.00811	CbGeAlD
Imatinib—NQO2—nervous system—attention deficit hyperactivity disorder	0.00506	0.0078	CbGeAlD
Imatinib—PDGFRA—nervous system—attention deficit hyperactivity disorder	0.00505	0.00778	CbGeAlD
Imatinib—CA3—brain—attention deficit hyperactivity disorder	0.00503	0.00775	CbGeAlD
Imatinib—KIT—midbrain—attention deficit hyperactivity disorder	0.00491	0.00756	CbGeAlD
Imatinib—NQO2—central nervous system—attention deficit hyperactivity disorder	0.00487	0.00751	CbGeAlD
Imatinib—PDGFRA—central nervous system—attention deficit hyperactivity disorder	0.00486	0.00749	CbGeAlD
Imatinib—PDGFRB—midbrain—attention deficit hyperactivity disorder	0.00479	0.00739	CbGeAlD
Imatinib—NQO2—cerebellum—attention deficit hyperactivity disorder	0.00476	0.00734	CbGeAlD
Imatinib—PDGFRA—cerebellum—attention deficit hyperactivity disorder	0.00475	0.00732	CbGeAlD
Imatinib—CA12—nervous system—attention deficit hyperactivity disorder	0.00466	0.00718	CbGeAlD
Imatinib—CA14—brain—attention deficit hyperactivity disorder	0.00456	0.00704	CbGeAlD
Imatinib—CA12—central nervous system—attention deficit hyperactivity disorder	0.00448	0.00691	CbGeAlD
Imatinib—CSF1R—nervous system—attention deficit hyperactivity disorder	0.00444	0.00685	CbGeAlD
Imatinib—CA2—forebrain—attention deficit hyperactivity disorder	0.0044	0.00679	CbGeAlD
Imatinib—CSF1R—central nervous system—attention deficit hyperactivity disorder	0.00428	0.00659	CbGeAlD
Imatinib—ABL1—midbrain—attention deficit hyperactivity disorder	0.00427	0.00658	CbGeAlD
Imatinib—CSF1R—cerebellum—attention deficit hyperactivity disorder	0.00418	0.00644	CbGeAlD
Imatinib—SLC47A1—nervous system—attention deficit hyperactivity disorder	0.00406	0.00625	CbGeAlD
Imatinib—KIT—nervous system—attention deficit hyperactivity disorder	0.00403	0.00622	CbGeAlD
Imatinib—PDGFRB—nervous system—attention deficit hyperactivity disorder	0.00394	0.00607	CbGeAlD
Imatinib—SLC47A1—central nervous system—attention deficit hyperactivity disorder	0.00391	0.00602	CbGeAlD
Imatinib—KIT—central nervous system—attention deficit hyperactivity disorder	0.00388	0.00599	CbGeAlD
Imatinib—NQO2—brain—attention deficit hyperactivity disorder	0.00387	0.00596	CbGeAlD
Imatinib—PDGFRA—brain—attention deficit hyperactivity disorder	0.00386	0.00594	CbGeAlD
Imatinib—SLC47A1—cerebellum—attention deficit hyperactivity disorder	0.00382	0.00588	CbGeAlD
Imatinib—KIT—cerebellum—attention deficit hyperactivity disorder	0.0038	0.00585	CbGeAlD
Imatinib—PDGFRB—central nervous system—attention deficit hyperactivity disorder	0.00379	0.00585	CbGeAlD
Imatinib—CA2—cardiovascular system—attention deficit hyperactivity disorder	0.00372	0.00574	CbGeAlD
Imatinib—PDGFRB—cerebellum—attention deficit hyperactivity disorder	0.00371	0.00571	CbGeAlD
Imatinib—ORM1—nervous system—attention deficit hyperactivity disorder	0.0037	0.0057	CbGeAlD
Imatinib—CA1—nervous system—attention deficit hyperactivity disorder	0.00369	0.00569	CbGeAlD
Imatinib—CA12—brain—attention deficit hyperactivity disorder	0.00356	0.00549	CbGeAlD
Imatinib—ORM1—central nervous system—attention deficit hyperactivity disorder	0.00356	0.00548	CbGeAlD
Imatinib—CA1—central nervous system—attention deficit hyperactivity disorder	0.00355	0.00548	CbGeAlD
Imatinib—ABL1—nervous system—attention deficit hyperactivity disorder	0.00351	0.00541	CbGeAlD
Imatinib—PTGS1—forebrain—attention deficit hyperactivity disorder	0.0034	0.00524	CbGeAlD
Imatinib—CSF1R—brain—attention deficit hyperactivity disorder	0.0034	0.00523	CbGeAlD
Imatinib—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.00339	0.00522	CbGeAlD
Imatinib—ABL1—central nervous system—attention deficit hyperactivity disorder	0.00338	0.00521	CbGeAlD
Imatinib—ABL1—cerebellum—attention deficit hyperactivity disorder	0.0033	0.00509	CbGeAlD
Imatinib—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.00326	0.00502	CbGeAlD
Imatinib—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00315	0.00486	CbGeAlD
Imatinib—SLC47A1—brain—attention deficit hyperactivity disorder	0.0031	0.00478	CbGeAlD
Imatinib—KIT—brain—attention deficit hyperactivity disorder	0.00308	0.00475	CbGeAlD
Imatinib—PDGFRB—brain—attention deficit hyperactivity disorder	0.00301	0.00464	CbGeAlD
Imatinib—CA2—midbrain—attention deficit hyperactivity disorder	0.00291	0.00448	CbGeAlD
Imatinib—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00288	0.00443	CbGeAlD
Imatinib—CA1—brain—attention deficit hyperactivity disorder	0.00282	0.00435	CbGeAlD
Imatinib—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0028	0.00431	CbGeAlD
Imatinib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00269	0.00415	CbGeAlD
Imatinib—ABL1—brain—attention deficit hyperactivity disorder	0.00268	0.00414	CbGeAlD
Imatinib—SLC22A1—brain—attention deficit hyperactivity disorder	0.00259	0.00399	CbGeAlD
Imatinib—ALB—brain—attention deficit hyperactivity disorder	0.00248	0.00382	CbGeAlD
Imatinib—CA2—nervous system—attention deficit hyperactivity disorder	0.00239	0.00369	CbGeAlD
Imatinib—CA2—central nervous system—attention deficit hyperactivity disorder	0.0023	0.00355	CbGeAlD
Imatinib—CA2—cerebellum—attention deficit hyperactivity disorder	0.00225	0.00347	CbGeAlD
Imatinib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00208	0.00321	CbGeAlD
Imatinib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00201	0.0031	CbGeAlD
Imatinib—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00185	0.00285	CbGeAlD
Imatinib—CA2—brain—attention deficit hyperactivity disorder	0.00183	0.00282	CbGeAlD
Imatinib—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00178	0.00274	CbGeAlD
Imatinib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.0017	0.00262	CbGeAlD
Imatinib—ABCG2—brain—attention deficit hyperactivity disorder	0.00169	0.00261	CbGeAlD
Imatinib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00154	0.00238	CbGeAlD
Imatinib—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00152	0.00234	CbGeAlD
Imatinib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00149	0.00229	CbGeAlD
Imatinib—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00146	0.00225	CbGeAlD
Imatinib—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00143	0.0022	CbGeAlD
Imatinib—PTGS1—brain—attention deficit hyperactivity disorder	0.00141	0.00218	CbGeAlD
Imatinib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00133	0.00205	CbGeAlD
Imatinib—CYP2D6—brain—attention deficit hyperactivity disorder	0.00116	0.00179	CbGeAlD
Imatinib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00109	0.00168	CbGeAlD
Imatinib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00105	0.00162	CbGeAlD
Imatinib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00103	0.00158	CbGeAlD
Imatinib—ABCB1—brain—attention deficit hyperactivity disorder	0.000835	0.00129	CbGeAlD
Imatinib—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000278	0.000791	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000277	0.00079	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000276	0.000786	CbGpPWpGaD
Imatinib—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000276	0.000784	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000274	0.00078	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000273	0.000778	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00027	0.000769	CbGpPWpGaD
Imatinib—CA1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000267	0.000761	CbGpPWpGaD
Imatinib—LCK—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000266	0.000758	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000265	0.000753	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000264	0.000753	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000263	0.00075	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000259	0.000739	CbGpPWpGaD
Imatinib—CA9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000247	0.000703	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000243	0.000693	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000239	0.00068	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000238	0.000678	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000237	0.000676	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000237	0.000675	CbGpPWpGaD
Imatinib—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000235	0.00067	CbGpPWpGaD
Imatinib—CA9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000235	0.000669	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000235	0.000669	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000234	0.000665	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000231	0.000658	CbGpPWpGaD
Imatinib—CA3—Metabolism—EP300—attention deficit hyperactivity disorder	0.000229	0.000653	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000227	0.000647	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000226	0.000644	CbGpPWpGaD
Imatinib—KIT—Disease—SNAP25—attention deficit hyperactivity disorder	0.000225	0.00064	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000224	0.000638	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000224	0.000637	CbGpPWpGaD
Imatinib—CA2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000222	0.000632	CbGpPWpGaD
Imatinib—CA2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.00022	0.000628	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000219	0.000624	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000217	0.000619	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000215	0.000612	CbGpPWpGaD
Imatinib—CA1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000213	0.000606	CbGpPWpGaD
Imatinib—PDGFRA—Disease—SNAP25—attention deficit hyperactivity disorder	0.000213	0.000606	CbGpPWpGaD
Imatinib—CA1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000211	0.000602	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000209	0.000594	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000208	0.000592	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.000582	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000202	0.000575	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000195	0.000556	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000194	0.000551	CbGpPWpGaD
Imatinib—PDGFRB—Disease—SNAP25—attention deficit hyperactivity disorder	0.000192	0.000546	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000191	0.000544	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000188	0.000536	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000188	0.000534	CbGpPWpGaD
Imatinib—CA9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000187	0.000533	CbGpPWpGaD
Imatinib—CA9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000186	0.000529	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000184	0.000524	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000183	0.000522	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000183	0.000521	CbGpPWpGaD
Imatinib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000182	0.000517	CbGpPWpGaD
Imatinib—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000181	0.000515	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000169	0.000482	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000165	0.00047	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000162	0.000461	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00016	0.000456	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000157	0.000448	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000156	0.000444	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000156	0.000444	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000155	0.000441	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000155	0.000441	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000154	0.00044	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000154	0.00044	CbGpPWpGaD
Imatinib—LCK—Disease—SNAP25—attention deficit hyperactivity disorder	0.000154	0.000438	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000154	0.000437	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000152	0.000434	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000152	0.000433	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000152	0.000433	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00015	0.000427	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00015	0.000427	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00015	0.000427	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000149	0.000424	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000148	0.000421	CbGpPWpGaD
Imatinib—CA14—Metabolism—EP300—attention deficit hyperactivity disorder	0.000148	0.000421	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000148	0.00042	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000147	0.000417	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000144	0.000411	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000144	0.000411	CbGpPWpGaD
Imatinib—CA6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000144	0.00041	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000144	0.00041	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000144	0.00041	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000143	0.000406	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000142	0.000404	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.000403	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000142	0.000403	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000141	0.000402	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00014	0.000399	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00014	0.000397	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000138	0.000392	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000137	0.000391	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000136	0.000387	CbGpPWpGaD
Imatinib—CA7—Metabolism—EP300—attention deficit hyperactivity disorder	0.000134	0.000383	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000134	0.000382	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000133	0.000377	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000132	0.000375	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000375	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000131	0.000372	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00013	0.00037	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000129	0.000366	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000128	0.000366	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000128	0.000364	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000128	0.000364	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000126	0.000359	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000125	0.000357	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000125	0.000357	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000125	0.000355	CbGpPWpGaD
Imatinib—CA12—Metabolism—EP300—attention deficit hyperactivity disorder	0.000125	0.000355	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000352	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000352	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000122	0.000348	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000341	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000119	0.000338	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000118	0.000336	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.000335	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.000335	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000118	0.000335	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000116	0.00033	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000116	0.00033	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000115	0.000328	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000115	0.000328	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000114	0.000325	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000114	0.000325	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000113	0.000321	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000112	0.000318	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000112	0.000318	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00011	0.000313	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000312	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000108	0.000307	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000104	0.000297	CbGpPWpGaD
Imatinib—LCK—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000103	0.000294	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000292	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000102	0.000291	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000101	0.000288	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.76e-05	0.000278	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.66e-05	0.000275	CbGpPWpGaD
Imatinib—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	9.63e-05	0.000274	CbGpPWpGaD
Imatinib—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.63e-05	0.000274	CbGpPWpGaD
Imatinib—CA2—Metabolism—EP300—attention deficit hyperactivity disorder	9.52e-05	0.000271	CbGpPWpGaD
Imatinib—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	9.48e-05	0.00027	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	9.46e-05	0.000269	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.43e-05	0.000269	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.39e-05	0.000267	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	9.37e-05	0.000267	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	9.36e-05	0.000266	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	9.31e-05	0.000265	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.3e-05	0.000265	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.29e-05	0.000265	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.14e-05	0.00026	CbGpPWpGaD
Imatinib—CA1—Metabolism—EP300—attention deficit hyperactivity disorder	9.13e-05	0.00026	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	9.09e-05	0.000259	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.02e-05	0.000257	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.94e-05	0.000255	CbGpPWpGaD
Imatinib—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.81e-05	0.000251	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	8.75e-05	0.000249	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.72e-05	0.000248	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.66e-05	0.000247	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	8.65e-05	0.000246	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.65e-05	0.000246	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.51e-05	0.000242	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	8.51e-05	0.000242	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	8.44e-05	0.00024	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	8.44e-05	0.00024	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	8.3e-05	0.000236	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.23e-05	0.000234	CbGpPWpGaD
Imatinib—CA9—Metabolism—EP300—attention deficit hyperactivity disorder	8.03e-05	0.000228	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	7.95e-05	0.000226	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.95e-05	0.000226	CbGpPWpGaD
Imatinib—KIT—Immune System—EP300—attention deficit hyperactivity disorder	7.91e-05	0.000225	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.91e-05	0.000225	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	7.88e-05	0.000224	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.88e-05	0.000224	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	7.82e-05	0.000223	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	7.76e-05	0.000221	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.72e-05	0.00022	CbGpPWpGaD
Imatinib—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.7e-05	0.000219	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.53e-05	0.000214	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EP300—attention deficit hyperactivity disorder	7.49e-05	0.000213	CbGpPWpGaD
Imatinib—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.33e-05	0.000209	CbGpPWpGaD
Imatinib—KIT—Disease—EP300—attention deficit hyperactivity disorder	7.31e-05	0.000208	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.27e-05	0.000207	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.21e-05	0.000205	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.98e-05	0.000199	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EP300—attention deficit hyperactivity disorder	6.91e-05	0.000197	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.91e-05	0.000197	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	6.78e-05	0.000193	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EP300—attention deficit hyperactivity disorder	6.75e-05	0.000192	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.75e-05	0.000192	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	6.74e-05	0.000192	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.74e-05	0.000192	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	6.73e-05	0.000192	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	6.63e-05	0.000189	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.61e-05	0.000188	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.58e-05	0.000187	CbGpPWpGaD
Imatinib—ABL1—Immune System—EP300—attention deficit hyperactivity disorder	6.58e-05	0.000187	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.42e-05	0.000183	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.36e-05	0.000181	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.3e-05	0.000179	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EP300—attention deficit hyperactivity disorder	6.23e-05	0.000177	CbGpPWpGaD
Imatinib—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	6.17e-05	0.000176	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.16e-05	0.000175	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.05e-05	0.000172	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6e-05	0.000171	CbGpPWpGaD
Imatinib—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	5.84e-05	0.000166	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	5.8e-05	0.000165	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.62e-05	0.00016	CbGpPWpGaD
Imatinib—LCK—Immune System—EP300—attention deficit hyperactivity disorder	5.41e-05	0.000154	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.39e-05	0.000153	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.24e-05	0.000149	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.2e-05	0.000148	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.2e-05	0.000148	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.2e-05	0.000148	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.13e-05	0.000146	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.12e-05	0.000146	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.12e-05	0.000146	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.11e-05	0.000146	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.08e-05	0.000145	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.04e-05	0.000144	CbGpPWpGaD
Imatinib—LCK—Disease—EP300—attention deficit hyperactivity disorder	5e-05	0.000142	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.84e-05	0.000138	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.82e-05	0.000137	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.78e-05	0.000136	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	4.78e-05	0.000136	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.76e-05	0.000135	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	4.74e-05	0.000135	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.6e-05	0.000131	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.36e-05	0.000124	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.16e-05	0.000118	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	4.08e-05	0.000116	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.06e-05	0.000115	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.05e-05	0.000115	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	4.02e-05	0.000114	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.01e-05	0.000114	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.96e-05	0.000113	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.93e-05	0.000112	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	3.9e-05	0.000111	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.74e-05	0.000107	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.5e-05	9.97e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.15e-05	8.97e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.13e-05	8.91e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	2.91e-05	8.27e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.5e-05	7.13e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.25e-05	6.4e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.19e-05	6.24e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.07e-05	5.88e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	2.05e-05	5.83e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.75e-05	4.98e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.35e-05	3.85e-05	CbGpPWpGaD
